RecruitingNCT00505245

New Assessment System in Measuring Symptom Distress in Cancer Patients

Measuring the Symptom Distress of Cancer Patients: Development of a New Assessment System


Sponsor

M.D. Anderson Cancer Center

Enrollment

6,500 participants

Start Date

Apr 13, 1999

Study Type

OBSERVATIONAL

Conditions

Summary

This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Interview, Quality-of-Life Assessment, and others for people with caregiver, health care provider, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERInterview

Complete interview

OTHERQuality-of-Life Assessment

Complete quality of life assessment

OTHERQuestionnaire Administration

Complete questionnaires


Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00505245


Related Trials